ProMIS Neurosciences

ProMIS Neurosciences is a company listed under the stock ticker PMN (US).

View the org chart displaying its 13 main executives

Neil Warma, who was Independent Director, is promoted to Interim Chief Executive Officer and Director (posted on January 4 2024).
Gail Farfel, Chief Executive Officer, has left the company (posted on January 4 2024).

Create your alert
to follow the executive moves at ProMIS Neurosciences.

Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
Histogen has filed for bankruptcy protection (posted on April 19 2024).
Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).

Contact by email its executives including Neil Warma Premium

The best decision-maker directory

Discover the organization charts of your favorite companies.

Spot the influential executives using our search tools.

Receive notifications when executive positions change.

Fuel your company's success with our real-time data.

Individual Access

Executive Data Sets

Executives

Companies

The Official Board